Showing results (281-290 of 417) with videos related to
Sort By:
Pageof 42
AAPS Pharmsci|July 10, 2002
Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humansCynthia Sung, Tom J Parry, Todd A Riccobene, et al.Angewandte Chemie (International Ed. in English)|January 30, 2018
Mono-allyloxylated Cucurbit[7]uril Acts as an Unconventional Amphiphile To Form Light-Responsive VesiclesKyeng Min Park, Kangkyun Baek, Young Ho Ko, et al.Vaccine|May 16, 2002
Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectorsChelsea M Byrd, Tove' C Bolken, Kevin F Jones, et al.American Journal of Surgery|March 23, 2021
Peri-operative blood transfusion and risk of infectious complications following intestinal-cutaneous fistula surgical repair: A retrospective nationwide analysisOsaid Alser, Mathias A Christensen, Noelle Saillant, et al.Biodiversity Data Journal|May 30, 2015
Integrating and visualizing primary data from prospective and legacy taxonomic literatureJeremy A Miller, Donat Agosti, Lyubomir Penev, et al.Journal of Intensive Care Medicine|July 13, 2016
The Association of Age With Short-Term and Long-Term Mortality in Adults Admitted to the Intensive Care UnitRaghu R Seethala, Kevin Blackney, Peter Hou, et al.Oncotarget|November 19, 2014
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cellsJonathan D Moore, Anna Staniszewska, Terence Shaw, et al.Plos One|April 2, 2021
The relationship between vitamin D status, intake and exercise performance in UK University-level athletes and healthy inactive controlsSaskia L Wilson-Barnes, Julie E A Hunt, Jeewaka Mendis, et al.American Journal of Surgery|September 3, 2018
Can the emergency surgery score (ESS) be used as a triage tool predicting the postoperative need for an ICU admission?Napaporn Kongkaewpaisan, Jae Moo Lee, Ahmed I Eid, et al.Journal of Hematology & Oncology|July 9, 2013
A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)Daniel R Greenwald, Hailun Li, Selina M Luger, et al.Pageof 42